Investing.com — Specialty Chemical Company Stocks Lanxess (ETR: ) rose in early afternoon trading after reporting adjusted fourth-quarter 2024 earnings that beat market expectations. A better-than-expected performance in December largely contributed to this.
The company’s shares rose 5.6% to 25.90 euros after the announcement.
On Monday, Lanxess revealed preliminary numbers, expecting to report approximately 159 million euros ($163.4 million) in extraordinary earnings before interest, taxes, depreciation and amortization (Ebitda) for the fourth quarter. This estimate exceeds market expectations of €130 million for the same metric.
The company attributed a positive fourth quarter, particularly a strong performance in December, to forward buying. This trend was primarily observed in the USA, and the main drivers were special additives and consumer protection products.
The fourth-quarter performance is expected to push previously outstanding Ebitda to around €614m, up 20% from 2023, according to Lanxess.
Despite the strong performance in December, Lanxess warned that the underlying macroeconomic environment approaching 2025 showed no signs of improvement.
This article was generated with the support of artificial intelligence and reviewed by an editor. See our T&C for more information.
